NNV-011

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNNV-011
Drug Alias Namechimeric anti-CD37 antibody radionuclide conjugate (Nordic Nanovector)NNV-011
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate
Mechanisms of ActionLeukocyte antigen CD37 antagonists
TargetsLeukocyte antigen CD37
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusSuspended
Highest Status in ChinaN/A
Originator CompaniesNordic Nanovector Asa
China Registration ClassN/A

Develop Information

Active CompaniesPaul Scherrer InstitutNordic Nanovector Asa
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A